FunPep Company Limited AI Stock Analysis
Want to see JP:4881 full AI Analyst Report?
FunPep Company Limited (4881) AI Stock Analysis
FunPep Company Limited
(TSE/TYO:4881)
The exceptionally low overall score is driven primarily by severe financial deterioration, marked by a near-total revenue collapse, massive cash burn, and widening net losses. Compounding the fundamental weakness are deeply bearish technical trends and a highly negative valuation, making this an extraordinarily high-risk profile.
FunPep Company Limited (4881) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 1.98B
- Dividend Yield
- ―
- Average Volume (3M)
- 197.24K
- Price to Earnings (P/E)
- -1.1
- Beta (1Y)
- 0.75
- Revenue Growth
- -27.93%
- EPS Growth
- 22.36%
- Country
- Japan
- Employees
- 15
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
FunPep Company Limited Business Overview & Revenue Model
Company Description
FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-...
FunPep Company Limited Financial Statement Overview
Summary
Revenue has nearly collapsed alongside accelerating cash burn and drastically widening losses, anchoring the score at the absolute minimum despite the presence of a debt-free balance sheet.
Income Statement
5Very NegativeBalance Sheet
35NegativeCash Flow
10Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.12M | 314.00K | 6.13M | 530.00K | 1.07M | 126.87M |
| Gross Profit | -20.36M | -41.58M | -37.86M | -43.03M | -12.84M | 125.12M |
| EBITDA | -1.26B | -1.61B | -859.23M | -950.54M | -1.16B | -743.67M |
| Net Income | -1.58B | -1.91B | -889.09M | -933.42M | -1.17B | -682.26M |
Balance Sheet | ||||||
| Total Assets | 2.11B | 1.98B | 3.11B | 2.49B | 2.99B | 3.36B |
| Cash, Cash Equivalents and Short-Term Investments | 1.89B | 1.77B | 2.35B | 1.79B | 2.25B | 3.01B |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 433.93M | 516.73M | 566.27M | 192.61M | 298.11M | 188.67M |
| Stockholders Equity | 1.68B | 1.46B | 2.55B | 2.30B | 2.69B | 3.18B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.39B | -537.60M | -989.87M | -1.07B | -892.79M |
| Operating Cash Flow | 0 | -1.39B | -536.74M | -988.82M | -1.05B | -887.47M |
| Investing Cash Flow | 0 | -993.00K | -30.83M | -1.05M | -19.14M | -4.75M |
| Financing Cash Flow | 0 | 810.93M | 1.12B | 537.81M | 245.13M | 282.68M |
FunPep Company Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4881, the sentiment is Negative. The current price of 39.00 is below the 20-day moving average (MA) of 41.00, below the 50-day MA of 45.68, and below the 200-day MA of 66.36, indicating a bearish trend. The MACD of -1.80 indicates Negative momentum. The RSI at 36.83 is Neutral, neither overbought nor oversold. The STOCH value of 76.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4881.
FunPep Company Limited Peers Comparison
Overall Rating
JP:457081Outperform
JP:218350Neutral
JP:458748Neutral
JP:177A45Neutral
JP:457141Neutral- JP:488138Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4570 | 81Outperform | JPY 8.67B | 22.84 | ― | 0.65% | 7.10% | 17.17% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:2183 | 50Neutral | JPY 4.40B | -1.16 | ― | 4.12% | -21.55% | -497.97% |
| JP:4587 | 48Neutral | JPY 140.34B | -47.42 | -5.85% | ― | 14.25% | 50.07% |
| JP:177A | 45Neutral | JPY 3.42B | 26.76 | ― | 1.51% | -9.46% | -82.25% |
| JP:4571 | 41Neutral | JPY 6.37B | -4.98 | -33.61% | ― | 48.92% | -46.91% |
| JP:4881 | 38Underperform | JPY 2.08B | -1.13 | ― | ― | -27.93% | 22.36% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4881 | FunPep Company Limited | 39.00 | -50.00 | -56.18% | |
| JP:4587 | Peptidream | 1065.00 | -518.50 | -32.74% | |
| JP:4571 | NanoCarrier Co., Ltd. | 67.00 | -83.00 | -55.33% | |
| JP:177A | Kohjin Bio Co.,Ltd. | 664.00 | -895.84 | -57.43% | |
| JP:2183 | Linical Co., Ltd. | 194.00 | -99.92 | -34.00% | |
| JP:4570 | Immuno-Biological Laboratories Co., Ltd. | 917.00 | 69.63 | 8.22% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 22, 2026